bromocriptine has been researched along with Experimental Mammary Neoplasms in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (88.64) | 18.7374 |
| 1990's | 5 (11.36) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arafah, BM; Finegan, HM; Manni, A; Pearson, OH; Rainieri, J | 1 |
| Djiane, J; Gandilhon, P; Kelly, PA; Mélançon, R | 1 |
| Imura, H; Kato, Y; Matsushita, N; Waseda, N | 1 |
| DeHoog, JV; Welsch, CW | 1 |
| Goya, RG; Sosa, YE | 1 |
| Gómez, CJ; Goya, RG; Sosa, YE | 1 |
| Aylsworth, CF; Meites, J; Sylvester, PW; Van Vugt, DA | 2 |
| Juneja, HS; Mhatre, MC; Shah, PN | 1 |
| Matsushima, R; Sumi, C; Yokoro, K | 2 |
| Cohen, LA | 1 |
| Noonan, JJ; Rose, DP | 1 |
| Brown, CK; Goodrich-Smith, M; Johnson, D; Mackie, D; Welsch, CW | 1 |
| Morii, S; Nagasawa, H | 2 |
| Mori, T; Nagasawa, H | 1 |
| MacLeod, RM; Nagy, I; Valdenegro, CA | 1 |
| Andrade, N; Bergoc, R; Caro, R; Cricco, G; Davio, C; Martin, G; Melito, G; Rivera, E | 1 |
| Anderson, TM; Brooks, CL; Brown, CK; Denenberg, B; Goodrich-Smith, M; Van, J; Welsch, CW | 1 |
| Chan, P; Cohen, L; Hill, P; Kuno, K; Wynder, E | 1 |
| Gullino, PM | 1 |
| Bowie, M; Boyar, RM; Budinger, JM; Hellman, L; Mountain, IM; Rosenberg, BJ; Stock, CC; Teller, MN | 1 |
| Brown, CK; Goodrich-Smith, M; Welsch, CW; Wilson, M | 1 |
| Medina, D | 1 |
| Hassett, CC; Lambrecht, LK; Welsch, CW | 1 |
| Adams, C; Brooks, CL; Hassett, CC; Lambrecht, LK; Welsch, CW | 1 |
| Briand, P; Daehnfeldt, JL; Thorpe, SM | 1 |
| Welsch, CW | 3 |
| El'tsina, NV | 1 |
| Friesen, HG; Holdaway, IM | 1 |
| Nagasawa, H; Yanai, R | 1 |
| Heppner, GH; Loeffler, DA; Tsai, SJ | 1 |
| Polyzonis, MB; Stravoravdi, P; Toliou, T | 1 |
| Cannon, M; Hu, L; Lawson, D; Ye, J | 1 |
| Cornelisse, CJ; Keijzer, R; van de Velde, CJ; van Dierendonck, JH; Wijsman, JH | 1 |
| Dauvois, S; Labrie, F; Spinola, PG | 1 |
| Bellussi, G; Conti, G; Di Carlo, F; Muccioli, G; Racca, S | 1 |
| Ip, C; Ip, MM; Sylvester, PW | 1 |
| Cleeve, HJ; Colston, KW; Hadcocks, L | 1 |
| Danguy, AJ; de Launoit, Y; Kiss, R; L'Hermite, M; L'Hermite-Balériaux, M; Paridaens, RJ; Pasteels, JL | 1 |
| Zaccheo, T | 1 |
2 review(s) available for bromocriptine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetonitriles; Androstanols; Animals; Breast Neoplasms; Bromocriptine; Drug Evaluation, Preclinical; Ergolines; Ergot Alkaloids; Estradiol; Female; Humans; Lisuride; Mammary Neoplasms, Experimental; Prolactin; Rats; Urea | 1977 |
[Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man].
Topics: Animals; Benz(a)Anthracenes; Breast; Breast Neoplasms; Bromocriptine; Cell Differentiation; Cell Transformation, Neoplastic; Female; Humans; Levodopa; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Prolactin | 1976 |
42 other study(ies) available for bromocriptine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Topics: Animals; Bromocriptine; Castration; Estradiol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Perphenazine; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin; Tamoxifen | 1982 |
N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Topics: Animals; Bromocriptine; Castration; Cytosol; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Receptors, Prolactin | 1983 |
Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Receptors, Prolactin; Tamoxifen | 1983 |
Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Bromocriptine; Cell Division; Diterpenes; Female; Kinetics; Mammary Neoplasms, Experimental; Mycobacterium bovis; Nocardia; Rats; Retinyl Esters; Tamoxifen; Vitamin A | 1983 |
Changes in chromatin composition associated with hormone-dependent mammary tumor regression.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Chromatin; DNA, Neoplasm; Female; Histones; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Rats; Rats, Inbred Strains | 1983 |
DNA synthesis during hormone-dependent mammary tumor regression in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; DNA Replication; Female; Kinetics; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1983 |
Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Castration; Estradiol; Female; Haloperidol; Mammary Neoplasms, Experimental; Ovary; Rats; Rats, Inbred Strains; Tamoxifen | 1983 |
Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Castration; Dietary Fats; Estradiol; Female; Haloperidol; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Cell Transformation, Neoplastic; Darkness; DNA; Estradiol; Female; Light; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Melatonin; Neoplasms, Radiation-Induced; Pregnancy; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Preventive effects of antioestrogen on mammary and pituitary tumorigenesis in rats.
Topics: Animals; Body Weight; Bromocriptine; Castration; Clomiphene; Diethylstilbestrol; Estrogen Antagonists; Male; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Pituitary Gland; Pituitary Neoplasms; Rats; Rats, Inbred Strains | 1984 |
Influence of chronic prolactin suppression during puberty on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Age Factors; Analysis of Variance; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Prolactin; Rats; Sexual Maturation | 1981 |
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Ergolines; Female; Growth Hormone; Hypophysectomy; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats | 1982 |
2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Rats; Rats, Inbred Strains; Tamoxifen; Time Factors | 1982 |
Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
Topics: Animals; Bromocriptine; Castration; Diethylstilbestrol; Epididymis; Male; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1983 |
Inhibition by early treatment with bromocriptine of spontaneous mammary tumour development in rats with no side-effects.
Topics: Age Factors; Animals; Bromocriptine; DNA; Female; Lactation; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Organ Size; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Inbred Strains; Reproduction | 1982 |
Stimulation of mammary tumorigenesis and suppression of uterine adenomyosis by temporary inhibition of pituitary prolactin secretion during youth in mice (41492).
Topics: Age Factors; Animals; Bromocriptine; Endometriosis; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Prolactin | 1982 |
Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
Topics: Age Factors; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Prolactin; Rats | 1981 |
Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
Topics: Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Rats; Tamoxifen; Transplantation, Homologous | 1980 |
Hormone dependence of mammary tumors induced in rats by intraperitoneal NMU injection.
Topics: Animals; Bromocriptine; Carcinogens; Estradiol; Female; Haloperidol; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Hormone-Dependent; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Tamoxifen | 1997 |
Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Precancerous Conditions; Prolactin; Rats; Time Factors | 1979 |
Diet and endocrine-related cancer.
Topics: Adult; Animals; Asian People; Breast Neoplasms; Bromocriptine; Dehydroepiandrosterone; Dietary Fats; Estrogens; Estrus; Female; Humans; Mammary Neoplasms, Experimental; Menstruation; Middle Aged; Pregnancy; Prolactin; Rats; White People | 1977 |
Considerations on the preneoplastic lesions of the mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast; Breast Neoplasms; Bromocriptine; Cell Transformation, Neoplastic; Cells, Cultured; Ergolines; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Neoplasm Transplantation; Precancerous Conditions; Transplantation, Heterologous; Urethane | 1977 |
Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Estrone; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Pregnancy; Progesterone; Prolactin | 1979 |
Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Ovary; Precancerous Conditions; Pyrrolidines; Receptors, Androgen; Receptors, Estrogen; Testosterone; Transplantation, Isogeneic | 1977 |
Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Topics: Adrenal Glands; Animals; Bromocriptine; Castration; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Precancerous Conditions; Prolactin | 1977 |
17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
Topics: Animals; Bromocriptine; Contraceptives, Oral; Contraceptives, Oral, Combined; Ergolines; Estradiol; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Mestranol; Mice; Norethynodrel | 1977 |
Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
Topics: Animals; Bromocriptine; Castration; Ergolines; Estrone; Female; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Progesterone; Prolactin; Transplantation, Homologous | 1977 |
Prolactin and the development and progression of early neoplastic mammary gland lesions.
Topics: Animals; Breast Neoplasms; Bromocriptine; Castration; DNA, Neoplasm; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Mestranol; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Norethynodrel; Organ Culture Techniques; Ovary; Parity; Placental Lactogen; Precancerous Conditions; Pregnancy; Prolactin; Transplantation, Heterologous | 1978 |
Correlation between hormone binding and growth response of rat mammary tumor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Biopsy; Bromocriptine; Estradiol; Female; Insulin; Mammary Neoplasms, Experimental; Prolactin; Rats | 1976 |
Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
Topics: Animals; Bromocriptine; DNA; Ergolines; Estrus; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Pituitary Gland; Pituitary Gland, Anterior; Pregnancy; Prolactin; Transplantation, Isogeneic | 1976 |
Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Topics: Animals; Bromocriptine; Drug Synergism; Ergolines; Estradiol; Estrogens; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Ovary; Pregnancy; Progesterone Congeners; Prolactin | 1976 |
Prophylaxis of early preneoplastic lesions of the mammary gland.
Topics: Animals; Bromocriptine; Ergolines; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metergoline; Mice; Mice, Inbred C3H; Parity; Precancerous Conditions; Prolactin | 1976 |
Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Topics: Animals; Bromocriptine; Drug Administration Schedule; Hyperplasia; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Precancerous Conditions; Prolactin | 1992 |
A new approach combining interferon and bromocriptine LA to prevent spontaneous mouse mammary carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Delayed-Action Preparations; Female; Interferons; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H | 1991 |
Bioactivity of plasma prolactin in ovariectomized, diethylstilbestrol-treated Long-Evans and Holtzman rats after thyrotropin-releasing hormone or bromocriptine administration.
Topics: Animals; Biological Assay; Bromocriptine; Diethylstilbestrol; Female; Mammary Neoplasms, Experimental; Ovariectomy; Prolactin; Radioimmunoassay; Rats; Species Specificity; Thyrotropin-Releasing Hormone | 1991 |
A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
Topics: Animals; Bromocriptine; Cell Division; DNA, Neoplasm; Drug Implants; Estradiol; Female; Flow Cytometry; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Perphenazine; Ploidies; Prolactin; Rats; Rats, Inbred Strains | 1991 |
Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1989 |
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
Topics: Adenocarcinoma; Animals; Bromocriptine; Female; Liver; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Prolactin | 1988 |
Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Dietary Fats; Estrogens; Female; Mammary Neoplasms, Experimental; Ovariectomy; Ovary; Prolactin; Rats; Tamoxifen | 1986 |
Comparison of alkaline phosphatase activity in normal, lactating and neoplastic rat mammary tissue.
Topics: Alkaline Phosphatase; Animals; Binding, Competitive; Bromocriptine; Female; Isoenzymes; Lactation; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Pregnancy; Rats; Rats, Inbred Strains | 1988 |
Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm.
Topics: Animals; Bromocriptine; Cell Division; Estradiol; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Prolactin; Sulpiride; Uterus | 1987 |
Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Mammary Neoplasms, Experimental; Mice; Prolactin | 1985 |